eye
Instructed patient about regular eye examination to detect early eye problems.
Patient was instructed on eyes complications. Diabetes can cause eye problems and may lead to blindness. People with diabetes do have a higher of blindness than people without diabetes. Early detection and treatment of eye problems can save the sight.
The patient was instructed in myasthenia gravis in finding required helpful equipment and procedures as the disease progresses. The patient was advised to use an eye patch over the affected eye or an ice-covered lens to improve vision if diplopia continues. The patient was taught to put on artificial tears to keep the corneas humid and free of abrasions.
SN instructed about the use of Januvia ( Sitagliptin ) is used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes. It works by increasing the amounts of certain natural substances that lower blood sugar when it is high. Over time, people who have diabetes and high blood sugar can develop serious or life - threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication,making lifestyle changes, and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes - related complications such as kidney failure, nerve damage, eye problems, including changes or loss of vision, or gum disease.
Instructed in new medication Calcium and in S/E such as headache, weakness, dizziness, paresthesia, chest pressure, facial flushing, edema of feet, eye pain, nasal congestion, transient nausea, unusual taste, diarrhea, anorexia, vomiting, epigastric discomfort, abdominal pain, increased urinary frequency, nocturia, shortness of breath, rash, pruritus of ear lobes, inflammation at injection site, hypersensitivity reactions (anaphylaxis), chills and tender palms and soles.
Instructed in possible complications of diabetes such as kidney and bladder disorders, strokes, heart disorders, eye complications, peripheral vascular disorders, nervous system disorders.
Instructed in new medication Aricept to manage moderate dementia of the Alzheimer type. In addition, warned of possible S/E such as headache, insomnia, dizziness, fatigue, depression, abnormal dreams, somnolence, seizures, tremor, irritability, paresthesia, aggression, vertigo, ataxia, restlessness, abnormal crying, nervousness, aphasia, syncope, pain, chest pain, hypertension, vasodilation, atrial fibrillation, hot flashes, hypotension, cataract, blurred vision, eye irritation, sore throat, nausea, diarrhea, vomiting, anorexia, fecal incontinence, GI bleeding, bloating, epigastric pain, frequent urination, ecchymosis, weight loss, dehydration, muscle cramps, arthritis, toothache, bone fracture, dyspnea, bronchitis, pruritus, urticaria, diaphoresis, influenza, and increased libido. The drug does not alter the underlying degenerative disease but can temporarily stabilize or relieve symptoms. Effective therapy depends on taking drug at regular intervals. Instructed to take drug in the evening, just before bedtime. Immediately report significant adverse effects or changes in overall health status. Inform health care team that patient is taking drug before he receives anesthesia. Avoid OTC cold or sleep remedies because of the potential for increased anticholinergic effects.
Instructed in measures important in management of diabetes mellitus: follow prescribed diabetic diet, see physician, dentist, and eye doctor regulary, take medications as ordered, exercise regularly.
Instructed patient on possible complications linked to diabetes such as, kidney, bladder and heart disorders, strokes, eye complications, peripheral vascular and nervous system disorders.
Instructed patient on important procedures in management of DM such as: follow prescribed diabetic diet, see physician, dentist and eye doctor regularly, take medications as ordered, exercise regularly.